Sorafenib plus transarterial chemoembolization for unresectable hepatocellular carcinoma

被引：1
|
作者：
Tsilimigras, Diamantis I. [1 ]
Pawlik, Timothy M.
机构：
[1] Ohio State Univ, Wexner Med Ctr, Div Surg Oncol, Dept Surg, 410 W 10th Ave,Columbus, Columbus, OH 43210 USA
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2020年 / 8卷 / 23期
关键词：
ENDOTHELIAL GROWTH-FACTOR; DRUG-ELUTING BEADS; PHASE-III; EXPRESSION; EFFICACY; JAPANESE; TRIAL;
D O I：
10.21037/atm-20-7228
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Clinical value of continuous administration of sorafenib in combination with modified transarterial chemoembolization in patients with unresectable hepatocellular carcinoma
    Huang Yong-hui
    Chen Wei
    Li Jia-ping
    Chen Bin
    Yang Jian-yong
    CHINESE MEDICAL JOURNAL, 2013, 126 (02) : 385 - 386
  • [42] PHASE II STUDY OF THE CONCURRENT COMBINATION OF CONVENTIONAL TRANSARTERIAL CHEMOEMBOLIZATION AND SORAFENIB FOR PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA
    Park, Joong-Won
    Kim, Hwi Young
    Ahn, Sang Bu
    Choi, Joon-Il
    Woo, Sang Myung
    Kim, Hyun-Beom
    KoH, Young Hwan
    Nam, Byung Ho
    HEPATOLOGY, 2011, 54 : 1443A - 1443A
  • [43] Clinical value of continuous administration of sorafenib in combination with modified transarterial chemoembolization in patients with unresectable hepatocellular carcinoma
    HUANG Yong-hui
    CHEN Wei
    LI Jia-ping
    CHEN Bin
    YANG Jian-yong
    中华医学杂志（英文版）, 2013, 126 (02) : 385 - 386
  • [44] Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Apatinib Compared with Conventional Transarterial Chemoembolization Plus Apatinib in the Treatment of Unresectable Hepatocellular Carcinoma
    Zhang, Weihua
    Chen, Lei
    Cao, Yanyan
    Sun, Bo
    Ren, Yanqiao
    Sun, Tao
    Zheng, Chuansheng
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 5391 - 5402
  • [45] Impact of combining Lenvatinib with Transarterial chemoembolization for unresectable hepatocellular carcinoma
    Long, Jianwu
    Liu, Longfei
    Yang, Xuefeng
    Lu, Xianzhou
    Qin, Lei
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2023, 39 (06) : 1847 - 1852
  • [46] Transarterial chemoembolization (TACE) plus Sorafenib compared to TACE alone in transplant recipients with hepatocellular carcinoma
    Abdelrahim, M.
    Fong, J.
    Esmail, A.
    Victor, D.
    Graviss, E. A.
    Nguyen, D. T.
    Moore, L. W.
    Saharia, A.
    McMillan, R.
    Kodali, S.
    Uosef, A.
    Elshawwaf, M.
    Heyne, K.
    Ghobrial, R. M.
    TRANSPLANTATION, 2022, 106 (8S) : 167 - 167
  • [47] The Effect of Alcohol Consumption in Unresectable Hepatocellular Carcinoma with Transarterial Chemoembolization
    Sun, Bo
    Zhang, Lijie
    Xiang, Dongqiao
    Li, Qing
    Ren, Yanqiao
    Cao, Yanyan
    Sun, Tao
    Zhang, Weihua
    Wu, Linxia
    Zhu, Licheng
    Chen, Lei
    Zhao, Huangxuan
    Zheng, Chuansheng
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [48] Safety and efficacy of transarterial chemoembolization plus sorafenib for hepatocellular carcinoma with portal venous tumour thrombus
    Pan, T.
    Li, X. -S.
    Xie, Q. -K.
    Wang, J. -P.
    Li, W.
    Wu, P. -H.
    Zhao, M.
    CLINICAL RADIOLOGY, 2014, 69 (12) : E553 - E561
  • [49] Is transarterial chemoembolization an option for all patients with unresectable hepatocellular carcinoma?
    Burroughs, Andrew
    Samonakis, Dirnitrios
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2004, 1 (02): : 78 - 79
  • [50] Association of transarterial chemoembolization with survival in patients with unresectable hepatocellular carcinoma
    Wang, Peng
    Sheng, Lili
    Wang, Guoxiang
    Wang, Heping
    Huang, Xinyu
    Yan, Xiaoxing
    Yang, Xiaohua
    Pei, Renguang
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (02) : 203 - 206
12345